ArticleFrontiers in oncology2026
Coexistence of rectal adenocarcinoma and rectal and lymph node tuberculosis: a case report with a limited narrative review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rectal cancer concurrent with regional tuberculosis is a rare clinical entity. Due to its similar clinical symptoms and imaging features, it is frequently misdiagnosed, which profoundly complicates patient management. Case presentation: A 72-year-old man with a history of pulmonary tuberculosis presented with three months of intermittent hematochezia and tenesmus. Because the patient self-reported the tuberculosis as cured and initial imaging showed no active pulmonary or evident extrapulmonary lesions, preoperative molecular tuberculosis screening was not initiated. Preoperative imaging and biopsy confirmed rectal adenocarcinoma, alongside clinically suspected (but not histologically proven) pulmonary metastases. After neoadjuvant chemoradiotherapy, further chemotherapy was halted due to severe myelosuppression. A Hartmann procedure was performed after stable disease was confirmed. Postoperative pathology showed rectal adenocarcinoma with no lymph node metastasis (0/24) but unexpectedly revealed granulomatous inflammation in lymph nodes and rectal tissue. TB DNA PCR was positive, providing molecular evidence supporting concurrent tuberculosis. The patient developed postoperative anal discharge and a clinically suspected tuberculosis-related presacral infectious process, which improved after local irrigation and systemic anti-tuberculosis therapy. At one year, there was no tumor recurrence or new tuberculosis. Conclusion: In patients with a history of pulmonary tuberculosis who present with rectal cancer, the possibility of concurrent rectal and lymph node tuberculosis should be carefully considered. This case highlights the significant diagnostic overlap between these conditions, the high risk of delayed tuberculosis recognition, and its critical impact on postoperative management. Maintaining a high index of suspicion and utilizing comprehensive pathological and molecular evaluations are essential for accurate differential diagnosis and optimized patient care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.